Product Code: 978-1-68038-596-0
Fluorescent In Situ Hybridization Probe Market Growth & Trends:
The global fluorescent in situ hybridization probe market size is expected to reach USD 1.49 billion by 2030, registering a CAGR of 7.6% over the forecast period. The increasing global population being prone to target diseases, such as cancer, leads to the rising demand for accurate and effective diagnostics. This is expected to boost the market growth. For instance, according to the American Cancer Society Cancer Statistics 2023, it was estimated that approximately 1.9 million new cancer cases will be diagnosed in the U.S. in 2023. The Australian Institute of Health and Welfare (AIHW) 2021 report indicates that there were an estimated 150,782 new cancer cases in Australia in 2021.
Furthermore, the ICMR 2021 Report suggests that the number of cancer patients in India is projected to increase from 26.7 million in 2021 to 29.8 million in 2025. The fluorescent in situ hybridization (FISH) technique serves various purposes, including the precise localization of specific DNA sequences, genetic disease diagnosis, gene mapping, and identification of new oncogenes associated with different types of cancers. The growing investment in cancer genomics is expected to drive the adoption and significance of FISH. In addition, supportive government initiatives, rising healthcare expenditure levels, and increasing awareness pertaining to the benefits associated with this technique are expected to fuel industry growth during the forecast period.
Furthermore, technological advancement in chromogenic in situ hybridization (CISH), such as higher storage time of analyzed samples for long-duration studies, is expected to fuel the demand for navigation systems in the coming years. FISH is most commonly used in the detection of genetic diseases, such as Angelman syndrome, Prader-Willi syndrome, chronic myelogenous leukemia, Down's syndrome, Velocardiofacial syndrome, 22q13 deletion syndrome, acute lymphoblastic leukemia (ALL), and cri-du-chat. According to a publication from the CDC in 2022, Down's syndrome is the most common genetic disorder, with almost one in every 700 newborns affected by the disorder.
The rising prevalence of the condition drives the need to provide efficient diagnostics for detecting these genetic diseases, which, in turn, drives the overall market growth. Furthermore, key participants are engaged in various strategies, such as product launches, partnerships & collaborations, and M&As, to expand their global footprint and maintain competitive position in the market. For instance, in March 2023, OGT (Sysmex Group) received IVDR certification for CytoCell FISH probes. The company is the first manufacturer of FISH probes to receive IVDR certification, showcasing its unwavering commitment to meeting the significantly more rigorous regulatory standards. This certification validates their products' enduring safety, dependability, and efficacy.
Fluorescent in Situ Hybridization Probe Market Report Highlights:
- On the basis of technology, the flow FISH segment dominated the market in 2022 owing to the high demand for diagnosis of bacterial, viral, and fungal diseases
- On the basis of type, miRNA is anticipated to grow at a significant CAGR over the forecast period driven by factors, such as increasing R&D and extensive usage of miRNA in cancer detection
- Based on applications, cancer diagnostics dominated the market with market in 2022 due to the rising prevalence of cancer among the population
- Asia Pacific is expected to register the fastest CAGR over the forecast period due to the rising prevalence of target diseases, improving healthcare facilities, and growing demand for IVD testing for disease detection
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.1.1. Segment Definitions
- 1.1.1.1. Technology Segment
- 1.1.1.2. Type Segment
- 1.1.1.3. Application Segment
- 1.1.1.4. End-use segment
- 1.2. Regional Scope
- 1.3. Estimates and Forecast Timeline
- 1.4. Objectives
- 1.4.1. Objective - 1
- 1.4.2. Objective - 2
- 1.4.3. Objective - 3
- 1.5. Research Methodology
- 1.6. Information Procurement
- 1.6.1. Purchased Database
- 1.6.2. GVR's Internal Database
- 1.6.3. Secondary Sources
- 1.6.4. Primary Research
- 1.7. Information or Data Analysis
- 1.7.1. Data Analysis Models
- 1.8. Market Formulation & Validation
- 1.9. Model Details
- 1.9.1. Commodity Flow Analysis
- 1.10. List of Secondary Sources
- 1.11. List of Abbreviations
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Technology and Type Snapshot
- 2.3. Application and End Use Snapshot
- 2.4. Competitive Landscape Snapshot
Chapter 3. FISH Probe Market Variables, Trends, & Scope
- 3.1. Market Segmentation and Scope
- 3.2. Market Lineage Outlook
- 3.2.1. Parent Market Outlook
- 3.2.2. Related/Ancillary Market Outlook
- 3.3. Market Dynamics
- 3.4. Market Restraint Analysis
- 3.5. Porter's Five Forces Analysis
- 3.6. PESTLE Analysis
- 3.7. Pipeline Analysis
Chapter 4. FISH Probe Market: Technology Estimates & Trend Analysis
- 4.1. Fish Probe Market: Technology Movement Analysis
- 4.2. Q FISH
- 4.2.1. Q FISH market estimates and forecasts, 2018 - 2030 (USD Million)
- 4.3. FLOW FISH
- 4.3.1. FLOW FISH market estimates and forecasts, 2018 - 2030 (USD Million)
- 4.4. Other FISH
- 4.4.1. Other FISH market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 5. FISH Probe Market: Type Estimates & Trend Analysis
- 5.1. FISH Probe Market: Type Movement Analysis
- 5.2. DNA
- 5.2.1. DNA market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.3. RNA
- 5.3.1. RNA market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.3.2. mRNA
- 5.3.2.1. mRNA market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.3.3. miRNA
- 5.3.3.1. miRNA market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.3.4. Others
- 5.3.4.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 6. FISH Probe Market: Application Estimates & Trend Analysis
- 6.1. FISH Probe Market: Application Movement Analysis
- 6.2. Cancer Research
- 6.2.1. Cancer Research Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.2.2. Lung
- 6.2.2.1. Lung market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.2.3. Breast
- 6.2.3.1. Breast market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.2.4. Bladder
- 6.2.4.1. Bladder market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.2.5. Hematological
- 6.2.5.1. Hematological market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.2.6. Gastric
- 6.2.6.1. Gastric market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.2.7. Prostrate
- 6.2.7.1. Prostrate market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.2.8. Cervical
- 6.2.8.1. Cervical market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.2.9. Others
- 6.2.9.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.3. Genetic Diseases
- 6.3.1. Genetic Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4. Other
- 6.4.1. Other Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. FISH Probe Market: End-use Estimates & Trend Analysis
- 7.1. Fish Probe Market: End-use Movement Analysis
- 7.2. Research
- 7.2.1. Research Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3. Clinical
- 7.3.1. Clinical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4. Companion Diagnostics
- 7.4.1. Companion Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. FISH Probe Market: Regional Business Analysis
- 8.1. Regional Market Snapshot
- 8.2. North America
- 8.2.1. North America FISH Probe Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.2.2. U.S.
- 8.2.2.1. U.S. FISH Probe Market, 2018 - 2030 (USD Million)
- 8.2.2.2. Key Country Dynamics
- 8.2.2.3. Regulatory Framework
- 8.2.2.4. Reimbursement Scenario
- 8.2.2.5. Competitive Scenario
- 8.2.3. CANADA
- 8.2.3.1. Canada FISH Probe Market, 2018 - 2030 (USD Million)
- 8.2.3.2. Key Country Dynamics
- 8.2.3.3. Regulatory Framework
- 8.2.3.4. Reimbursement Scenario
- 8.2.3.5. Competitive Scenario
- 8.3. Europe
- 8.3.1. Europe FISH Probe Market, 2018 - 2030 (USD Million)
- 8.3.2. UK
- 8.3.2.1. UK FISH Probe Market, 2018 - 2030 (USD Million)
- 8.3.2.2. Key Country Dynamics
- 8.3.2.3. Regulatory Framework
- 8.3.2.4. Reimbursement Scenario
- 8.3.2.5. Competitive Scenario
- 8.3.3. GERMANY
- 8.3.3.1. Germany FISH Probe Market, 2018 - 2030 (USD Million)
- 8.3.3.2. Key Country Dynamics
- 8.3.3.3. Regulatory Framework
- 8.3.3.4. Reimbursement Scenario
- 8.3.3.5. Competitive Scenario
- 8.3.4. SPAIN
- 8.3.4.1. Spain FISH Probe Market, 2018 - 2030 (USD Million)
- 8.3.4.2. Key Country Dynamics
- 8.3.4.3. Regulatory Framework
- 8.3.4.4. Reimbursement Scenario
- 8.3.4.5. Competitive Scenario
- 8.3.5. FRANCE
- 8.3.5.1. France FISH Probe Market, 2018 - 2030 (USD Million)
- 8.3.5.2. Key Country Dynamics
- 8.3.5.3. Regulatory Framework
- 8.3.5.4. Reimbursement Scenario
- 8.3.5.5. Competitive Scenario
- 8.3.6. ITALY
- 8.3.6.1. Italy FISH Probe Market, 2018 - 2030 (USD Million)
- 8.3.6.2. Key Country Dynamics
- 8.3.6.3. Regulatory Framework
- 8.3.6.4. Reimbursement Scenario
- 8.3.6.5. Competitive Scenario
- 8.3.7. DENMARK
- 8.3.7.1. Denmark FISH Probe Market, 2018 - 2030 (USD Million)
- 8.3.7.2. Key Country Dynamics
- 8.3.7.3. Regulatory Framework
- 8.3.7.4. Reimbursement Scenario
- 8.3.7.5. Competitive Scenario
- 8.3.8. SWEDEN
- 8.3.8.1. Sweden FISH Probe Market, 2018 - 2030 (USD Million)
- 8.3.8.2. Key Country Dynamics
- 8.3.8.3. Regulatory Framework
- 8.3.8.4. Reimbursement Scenario
- 8.3.8.5. Competitive Scenario
- 8.3.9. NORWAY
- 8.3.9.1. Norway FISH Probe Market, 2018 - 2030 (USD Million)
- 8.3.9.2. Key Country Dynamics
- 8.3.9.3. Regulatory Framework
- 8.3.9.4. Reimbursement Scenario
- 8.3.9.5. Competitive Scenario
- 8.4. Asia Pacific
- 8.4.1. Asia-Pacific FISH Probe Market, 2018 - 2030 (USD Million)
- 8.4.2. JAPAN
- 8.4.2.1. Japan FISH Probe Market, 2018 - 2030 (USD Million)
- 8.4.2.2. Key Country Dynamics
- 8.4.2.3. Regulatory Framework
- 8.4.2.4. Reimbursement Scenario
- 8.4.2.5. Competitive Scenario
- 8.4.3. CHINA
- 8.4.3.1. China FISH Probe Market, 2018 - 2030 (USD Million)
- 8.4.3.2. Key Country Dynamics
- 8.4.3.3. Regulatory Framework
- 8.4.3.4. Reimbursement Scenario
- 8.4.3.5. Competitive Scenario
- 8.4.4. INDIA
- 8.4.4.1. India FISH Probe Market, 2018 - 2030 (USD Million)
- 8.4.4.2. Key Country Dynamics
- 8.4.4.3. Regulatory Framework
- 8.4.4.4. Reimbursement Scenario
- 8.4.4.5. Competitive Scenario
- 8.4.5. SOUTH KOREA
- 8.4.5.1. South Korea FISH Probe Market, 2018 - 2030 (USD Million)
- 8.4.5.2. Key Country Dynamics
- 8.4.5.3. Regulatory Framework
- 8.4.5.4. Reimbursement Scenario
- 8.4.5.5. Competitive Scenario
- 8.4.6. THAILAND
- 8.4.6.1. Thailand FISH Probe Market, 2018 - 2030 (USD Million)
- 8.4.6.2. Key Country Dynamics
- 8.4.6.3. Regulatory Framework
- 8.4.6.4. Reimbursement Scenario
- 8.4.6.5. Competitive Scenario
- 8.4.7. AUSTRALIA
- 8.4.7.1. Australia FISH Probe Market, 2018 - 2030 (USD Million)
- 8.4.7.2. Key Country Dynamics
- 8.4.7.3. Regulatory Framework
- 8.4.7.4. Reimbursement Scenario
- 8.4.7.5. Competitive Scenario
- 8.5. Latin America
- 8.5.1. Latin America FISH Probe Market, 2018 - 2030 (USD Million)
- 8.5.2. BRAZIL
- 8.5.2.1. Brazil FISH Probe Market, 2018 - 2030 (USD Million)
- 8.5.2.2. Key Country Dynamics
- 8.5.2.3. Regulatory Framework
- 8.5.2.4. Reimbursement Scenario
- 8.5.2.5. Competitive Scenario
- 8.5.3. MEXICO
- 8.5.3.1. Mexico FISH Probe Market, 2018 - 2030 (USD Million)
- 8.5.3.2. Key Country Dynamics
- 8.5.3.3. Regulatory Framework
- 8.5.3.4. Reimbursement Scenario
- 8.5.3.5. Competitive Scenario
- 8.5.4. ARGENTINA
- 8.5.4.1. Argentina FISH Probe Market, 2018 - 2030 (USD Million)
- 8.5.4.2. Key Country Dynamics
- 8.5.4.3. Regulatory Framework
- 8.5.4.4. Reimbursement Scenario
- 8.5.4.5. Competitive Scenario
- 8.6. MEA
- 8.6.1. MEA FISH Probe Market, 2018 - 2030 (USD Million)
- 8.6.2. SOUTH AFRICA
- 8.6.2.1. South Africa FISH Probe Market, 2018 - 2030 (USD Million)
- 8.6.2.2. Key Country Dynamics
- 8.6.2.3. Regulatory Framework
- 8.6.2.4. Reimbursement Scenario
- 8.6.2.5. Competitive Scenario
- 8.6.3. SAUDI ARABIA
- 8.6.3.1. Saudi Arabia FISH Probe Market, 2018 - 2030 (USD Million)
- 8.6.3.2. Key Country Dynamics
- 8.6.3.3. Regulatory Framework
- 8.6.3.4. Reimbursement Scenario
- 8.6.3.5. Competitive Scenario
- 8.6.4. UAE
- 8.6.4.1. UAE FISH Probe Market, 2018 - 2030 (USD Million)
- 8.6.4.2. Key Country Dynamics
- 8.6.4.3. Regulatory Framework
- 8.6.4.4. Reimbursement Scenario
- 8.6.4.5. Competitive Scenario
- 8.6.5. KUWAIT
- 8.6.5.1. Kuwait FISH Probe Market, 2018 - 2030 (USD Million)
- 8.6.5.2. Key Country Dynamics
- 8.6.5.3. Regulatory Framework
- 8.6.5.4. Reimbursement Scenario
- 8.6.5.5. Competitive Scenario
Chapter 9. Competitive Landscape
- 9.1. Company Categorization
- 9.2. Strategy Mapping
- 9.2.1. NEW PRODUCT LAUNCH
- 9.2.2. PARTNERSHIPS
- 9.2.3. ACQUISITION
- 9.2.4. COLLABORATION
- 9.2.5. FUNDING
- 9.3. Key Company Market Share Analysis, 2022
- 9.4. Company Heat Map Analysis
- 9.5. Company Profiles
- 9.5.1. THERMO FISHER SCIENTIFIC INC.
- 9.5.1.1. Company Overview
- 9.5.1.2. Financial Performance
- 9.5.1.3. Product Benchmarking
- 9.5.1.4. Strategic Initiatives
- 9.5.2. PERKINELMER INC
- 9.5.2.1. Company Overview
- 9.5.2.2. Financial Performance
- 9.5.2.3. Product Benchmarking
- 9.5.2.4. Strategic Initiatives
- 9.5.3. BIODOT
- 9.5.3.1. Company Overview
- 9.5.3.2. Product Benchmarking
- 9.5.3.3. Strategic Initiatives
- 9.5.4. HORIZON DIAGNOSTICS
- 9.5.4.1. Company Overview
- 9.5.4.2. Product Benchmarking
- 9.5.4.3. Strategic Initiatives
- 9.5.5. MERCK KGAA
- 9.5.5.1. Company Overview
- 9.5.5.2. Financial Performance
- 9.5.5.3. Product Benchmarking
- 9.5.5.4. Strategic Initiatives
- 9.5.6. AGILENT TECHNOLOGIES
- 9.5.6.1. Company Overview
- 9.5.6.2. Financial Performance
- 9.5.6.3. Product Benchmarking
- 9.5.6.4. Strategic Initiatives
- 9.5.7. ABNOVA CORPORATION
- 9.5.7.1. Company Overview
- 9.5.7.2. Product Benchmarking
- 9.5.7.3. Strategic Initiatives
- 9.5.8. LGC BIOSEARCH TECHNOLOGIES INC.
- 9.5.8.1. Company Overview
- 9.5.8.2. Product Benchmarking
- 9.5.8.3. Strategic Initiatives
- 9.5.9. GENEMED BIOTECHNOLOGIES, INC.
- 9.5.9.1. Company Overview
- 9.5.9.2. Product Benchmarking
- 9.5.9.3. Strategic Initiatives
- 9.5.10. F. HOFFMANN-LA ROCHE LTD
- 9.5.10.1. Company Overview
- 9.5.10.2. Financial Performance
- 9.5.10.3. Product Benchmarking
- 9.5.10.4. Strategic Initiatives
- 9.5.11. OXFORD GENE TECHNOLOGY
- 9.5.11.1. Company Overview
- 9.5.11.2. Product Benchmarking
- 9.5.11.3. Strategic Initiatives
- 9.5.12. BIOCARE MEDICAL, LLC
- 9.5.12.1. Company Overview
- 9.5.12.2. Product Benchmarking
- 9.5.12.3. Strategic Initiatives
- 9.5.13. QIAGEN (EXIQON A/S)
- 9.5.13.1. Company Overview
- 9.5.13.2. Financial Performance
- 9.5.13.3. Product Benchmarking
- 9.5.13.4. Strategic Initiatives
- 9.5.14. GSP RESEARCH INSTITUTE, INC.
- 9.5.14.1. Company Overview
- 9.5.14.2. Product Benchmarking
- 9.5.14.3. Strategic Initiatives